MedPath

Acarbose

Acarbose Tablets

Approved
Approval ID

26bca6c9-074d-480d-bd57-1e8fa9b3d05e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 12, 2009

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Acarbose

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-5945
Application NumberANDA078470
Product Classification
M
Marketing Category
C73584
G
Generic Name
Acarbose
Product Specifications
Route of AdministrationORAL
Effective DateNovember 9, 2010
FDA Product Classification

INGREDIENTS (5)

ACARBOSEActive
Quantity: 25 mg in 1 1
Code: T58MSI464G
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Acarbose - FDA Drug Approval Details